Código QR (código de barras bidimensional)

Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma

Abstract Background: Recent studies have highlighted that TACE in conjunction with Lenvatinib (TACE-L) offers a promising adjunct therapy for advanced HCC patients, outperforming TACE plus Sorafenib (TACE-S). However, there has been a lack of research comparing these two regimens for intermediate HC...

Fuld beskrivelse

Na minha lista:
Principais autores: Moxuan Wang, Jiamin Cheng, Niansong Qian
Format: Artigo
Sprog:Inglês
Udgivet: Nature Portfolio 2024-10-01
Serier:Scientific Reports
Fag:
Intermediate-stage hepatocellular carcinoma
Lenvatinib
Sorafenib
Transcatheter arterial chemoembolization
Portal hypertension
Combination therapy
Online adgang:https://doi.org/10.1038/s41598-024-74801-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker